Fig. 5.
![Fig. 5. Effects of CrmA overexpression on the susceptibility of Jurkat cells to tumor-mediated apoptosis. / CrmA or control Neo-Jurkat cells were labeled with [3H]TdR and coincubated with tumor cells at a tumor-to-lymphocyte cell ratio of 40:1. As controls, these cells were treated with agonistic anti-Fas Ab (CH-11, 200 ng/mL) or VP-16 (20 μmol/L). Target cell death was determined at the indicated time points by measuring loss in 3H-labeled DNA. The error bars represent the SEM of 8 replicates.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/95/6/10.1182_blood.v95.6.2015/6/bloo00630005x.jpeg?Expires=1724229502&Signature=pM3WO8RqSboZKr5l9REAcl4-I9wSd8kkk6SBE1PBFtZ~5J59HCOmxi~tAjfLxJOg7DiZFPYQ3-LQUisQV6rpwgv2Hus10xo6j~6piG360ckqQwHoZ~ejpxmHN5fDXdIdCTU3COTpvknr-KuHt0BVxiIXDtd9joBm3vLlcOU6R8WUIV6ebUjlFEhlafn3wSn89jmXUdP7ktDD1iAIn~i2KEdUlgzVKcJK7-~aB3Q1zWl7zAfsN52DZfoJ4yrNifmmeqpzHqsB3eWJrAhhvnmr7lYmj5fFNfx42Ppndwm2mupArauKQU66btg~J1EmlNxMluYlJf1yJX8viqSA0zdSBQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Effects of CrmA overexpression on the susceptibility of Jurkat cells to tumor-mediated apoptosis.
CrmA or control Neo-Jurkat cells were labeled with [3H]TdR and coincubated with tumor cells at a tumor-to-lymphocyte cell ratio of 40:1. As controls, these cells were treated with agonistic anti-Fas Ab (CH-11, 200 ng/mL) or VP-16 (20 μmol/L). Target cell death was determined at the indicated time points by measuring loss in 3H-labeled DNA. The error bars represent the SEM of 8 replicates.
